You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Catheter for Large Volume Intraparenchymal Brain Therapies

    SBC: TWIN STAR TDS, LLC            Topic: 105

    DESCRIPTION provided by applicant Neurodegenerative and malignant diseases of the central nervous system affect millions of Americans These diseases are often devastating and difficult to treat and effective drug delivery remains a significant challenge Infusion of drugs nto the brain parenchyma using convection enhanced delivery CED allows direct treatment of lesions circumventing the bl ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. An Open Source Precision Medicine Platform for Cloud Operating Systems

    SBC: CUROVERSE, INC.            Topic: 400

    DESCRIPTION provided by applicant Rapid improvements in DNA sequencing and synthesis have the potential to usher in a new era of precision medicine To realize this vision however we must re imagine the computational and storage infrastructure used to manage and extract actionable results from the massive data sets made possible by widely available advances in DNA sequencing and synthetic bio ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Fluorescence Lifetime Dynamics to Understand Brain Neural Activities and Behavior

    SBC: CHISQUARE BIOIMAGING LLC            Topic: 500

    DESCRIPTION provided by applicant The overall objective of the proposed project is to create a compact robust and easy to use device that is capable of sensitive and quantitative detection of fluorescence lifetime indicators of physiological and biochemical dynamics deep in the brain of a freely moving mouse In contrast to fluorescence intensity based methods fluorescence lifetime can delin ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Transitioning Electronic Support for Public Health (ESP) from Lab to Marketplace

    SBC: Commonwealth Informatics, Inc.            Topic: 400

    DESCRIPTION provided by applicant Accurate and complete disease surveillance is critical to enable public health authorities to detect and respond to disease outbreaks epidemics and even bioterrorism events While legally required of healthcare practitioners and practices most notifiable disease reporting is still done manually or through limited automated laboratory test result reporting ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Electronics and computational hardware for ultra-high channel count electrophysio

    SBC: Leaflabs, LLC            Topic: 101

    DESCRIPTION provided by applicant The advent of in vivo multielectrode recording has indicated the importance of recording from large populations of neurons As a result there is much interest in creating new kinds of in vivo multielectrode arrays including the polytrode new kinds of microfabricated electrode arrays and new kinds of ultradense D electrode array And yet innovation on the ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Self-assembling density gradients for sickle cell diagnosis in low resource areas

    SBC: DAKTARI DIAGNOSTICS, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant The World Health Organization has recently recognized sickle cell disease as a major global health concern The highest rates of sickle cell disease and sickle cell trait are seen in malaria endemic developing countries which also have the most severe resource constraints especially on clinical laboratory infrastructure Daktari Diagnostics a person vent ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Small Molecule Inhibitors of trans-Translation with Broad Spectrum Antibacterial

    SBC: MICROBIOTIX, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Because of the emergence of resistance to known antibiotics there is a critical need for new antibacterial agents especially against Gram negative pathogens trans Translation is a biochemical pathway that is essential to many bacterial species including Neisseria gonorrhoeae Shigella flexneri and Mycoplasma spp A high throughput assay of trans translatio ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Mobile Health App to Reduce Diabetes in Latina Women with Prior Gestational Diabe

    SBC: Environment And Health Group, Inc.            Topic: NIMHD

    DESCRIPTION provided by applicant Hispanic women have the highest lifetime risk for type diabetes T DM A window of opportunity for preventing T DM exists for women with pregnancies complicated by gestational diabetes mellitus GDM Women with prior GDM face increased risk of T DM Hispanic women are at increased risk of GDM and those with GDM have higher relative risks for developing T D ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Development of Peptide Antibiotic Nucleic Acids

    SBC: NUBAD LLC            Topic: NIAID

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Selective agents against C. difficile infection

    SBC: NOVOBIOTIC PHARMACEUTICALS, LLC            Topic: NIAID

    DESCRIPTION provided by applicant The overall goal of this project is to develop a selective antibiotic against Clostridium difficile the major agent responsible for antibiotic induced diarrhea and colitis The pathogen can be carried in healthy individuals and is kept at bay by gut symbionts Antibiotic treatment suppresses the normal flora but spores of C difficile survive germinate and ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government